Investor Presentaiton
Investor presentation
Full year 2018
Slide 62
Solid insulin market leadership position in Region
Japan & Korea
Region Japan & Korea insulin market
by segment
Region Japan & Korea modern and new-
generation insulin volume market shares
Sanofi
Novo Nordisk
-
Eli Lilly
tMU
18
16
14
12
10
8-
6
2
0
Nov
2013
Device penetration
CAGR volume¹: 0.7%
MI and NGI penetration
Penetration
CAGR value¹: (2.1%)
100%
70%
60%
Fast-acting
50%
40%
80%
Premix
30%
20%
Long-acting
10%
60%
0%
Nov
2018
1 CAGR for 5-year period
MI: Modern insulin; NGI: New-generation insulin
Source: IQVIA monthly MAT Nov, 2018 volume and value figures
changing
diabetes
Nov
2013
Source: IQVIA monthly MAT Nov, 2018 volume figures, numbers do not add up to
100% due to rounding
51%
26%
24%
Nov
2018
novo nordiskView entire presentation